Switch to:
Synageva BioPharma Corp (NAS:GEVA)
EV/EBITDA
-17.37 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Synageva BioPharma Corp's enterprise value is $3,232.09 Mil. Synageva BioPharma Corp's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Dec. 2014 was $-186.06 Mil. Therefore, Synageva BioPharma Corp's EV/EBITDA ratio for today is -17.37.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Synageva BioPharma Corp's stock price is $99.54. Synageva BioPharma Corp's earnings per share for the trailing twelve months (TTM) ended in Dec. 2014 was $-5.87. Therefore, Synageva BioPharma Corp's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Synageva BioPharma Corp's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=3232.092/-186.062
=-17.37

Synageva BioPharma Corp's current Enterprise Value is $3,232.09 Mil.
Synageva BioPharma Corp's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Dec. 2014 was -35.069 (Mar. 2014 ) + -48.57 (Jun. 2014 ) + -46.757 (Sep. 2014 ) + -55.666 (Dec. 2014 ) = $-186.06 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Synageva BioPharma Corp's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=99.54/-5.873
=

Synageva BioPharma Corp's share price for today is $99.54.
Synageva BioPharma Corp's Earnings Per Share for the trailing twelve months (TTM) ended in Dec. 2014 was -1.16 (Mar. 2014 ) + -1.52 (Jun. 2014 ) + -1.46 (Sep. 2014 ) + -1.733 (Dec. 2014 ) = $-5.87.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
ev2ebitda -31.8324.252.330.130.53-3.15-17.01-23.58-17.52-14.17

Synageva BioPharma Corp Quarterly Data

Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14
ev2ebitda -33.59-23.58-26.09-15.16-17.50-17.52-19.27-21.02-11.23-14.17
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK